skip to navigation skip to content
Search

pharmaceuticals

Shirley Okere promoted to Director of Regional Quality Operations for Pfizer

Cambridge Executive MBA (EMBA) 2019 graduate Shirley Okere steps into new role. Shirley Okere (EMBA 2019) Cambridge Executive MBA graduate Shirley Okere (EMBA 2019) is now Director of Regional Quality Operations for Pfizer. Shirley works in the multinational pharmaceutical corporation's…

Read more

2019 emba shirleyokerepromoted 883x432 1

Working in pharma: the value of an EMBA

Three pharmaceutical professionals discuss how the Cambridge EMBA has helped their careers in the sector. The Cambridge Executive MBA programme attracts talented senior professionals from a variety of professions and industries. For EMBA participants working in the pharmaceutical sector, their…

Read more

2018 embanews workinginpharma

Working in pharma: the value of an EMBA

Three pharmaceutical professionals discuss how the Cambridge EMBA has helped their careers in the sector. The Cambridge Executive MBA programme attracts talented senior professionals from a variety of professions and industries. For EMBA participants working in the pharmaceutical sector, their…

Read more

2018 embanews workinginpharma

Pharmaceutical pipeline

Study on drug industry project selection by Dr Panos Markou, Professor Stelios Kavadias and Dr Nektarios Oraiopoulos of Cambridge Judge Business School wins Best Working Paper award at the annual meeting of the Institute for Operations Research and Management Science.…

Read more

2018 news pharmaceuticalpipeline 883x432 1

Manufacturing Chemist: Limits of drug repurposing

New research co-authored at Cambridge Judge Business School looks at drug repurposing and found that it’s not easy to find entirely new uses for existing molecules. The study is based on US Food and Drug Administration approvals and the full…

Read more

Limits of drug repurposing

Drug 'repurposing' has some high-profile wins, but a new study at Cambridge Judge Business School shows how hard it is to find entirely new uses for existing molecules. The "repurposing" of existing drugs can be valuable, but a new study…

Read more

2018 lowdown oraiopoulos drugrepurposing 883x432 1

The EU single market at 25

A conference at Cambridge Judge marked the 25th anniversary of the European Union's single market, in advance of a special issue of the Review of Industrial Organisation journal. There has been much progress, but plenty of work remains to translate…

Read more

2018 brainfood podcast euat25 featured 883x432 1

A framework for drug development

'Science is not enough' for ensuring commercial success of new drugs, so a new journal article co-authored by Dr Nektarios (Aris) Oraiopoulos of Cambridge Judge outlines a framework to help pharma companies align better with end-customer priorities. In most industries,…

Read more

2017 brainfood oraiopoulos frameworkfordrugdevelopment 883x432 1

European Pharmaceutical Review: SynBio: unlocking the commercial potential of a new bioscience industry

Magda Papadaki, Head of Manufacturing Innovation for ABPI and an alumna of Cambridge Judge Business School (MPhil in Bioscience Enterprise 2012), writes about the implications of synthetic biology for the pharmaceutical industry. “Ultimately, the UK needs a joined-up system with…

Read more

EMBA alumnus, Dr Rav Seeruthun, joins operational board of Roche UK

Dr Rav Seeruthun (EMBA 2013) is appointed to the operational board at Roche UK as Medical Director. Roche is the number one biotechnology company worldwide, with 17 marketed biopharmaceuticals, allowing better targeted-therapies for patients. Roche employs over 90,000 people globally…

Read more

2016 embanews ravseeruthunjoinsroche 883x432 1

Archives